(1)
The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban. FE 2014, 15 (1S), 3-4. https://doi.org/10.7175/fe.v15i1s.972.